Food–Medication Interaction Detector (CYP450)
Flags interactions between foods/nutrients and antidiabetics, statins, anticoagulants, and antihypertensives.
Quick order preview
Choose a diet plan, ebook, or workout plan to continue shopping.
| Parameter | Value | Parameter | Value |
|---|---|---|---|
|
Dosage
|
200 mcg |
Strength
|
200 mcg |
|
Pack Size
|
05909990926213 ¦ Rp ¦ 18616 60 kaps. 05909990335480 ¦ Rp ¦ Skasowane ¦ 28339 50 tabl. 05909990335497 ¦ Rp ¦ 28648 100 kaps. |
Form
|
Proszek do inhalacji w kapsułkach twardych |
Listen to the article content live
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Rejestry E-zdrowia
Ludzki
wziewna
09262
2024-05-16
Novartis Farmacéutica, S.A. Novartis Pharma GmbH
Hiszpania Niemcy
Novartis Farmacéutica, S.A. Novartis Pharma GmbH Novartis Poland Sp. z o.o.
Hiszpania Niemcy Polska
art. 15 ust. 1 pkt 2
Search for medications, check dosage, side effects and contraindications.
Explore dedicated Diets Premium ecosystem applications matched to this topic or cycle through more clinical tools.
Flags interactions between foods/nutrients and antidiabetics, statins, anticoagulants, and antihypertensives.
Detects absorption blockers between supplements, drugs, and morning coffee, aligning them with blood tests into a daily schedule.
Models blood glucose and insulin responses for any recipe, food, or diet day, factoring in fiber and lipid buffering.
Estimates body fat percentage and lean muscle mass from neck, waist, and hip circumferences.